| 🇦🇫 Key Metrics by Year with Totals | ||||||
|---|---|---|---|---|---|---|
| Indicator | 2022 | 2023 | 2024 | 2025 | Overall | Trends |
| Suspected Cases | 389.0 | 1,243.0 | 1,221.0 | 71.0 | 2,924.0 | |
| Confirmed | 103.0 | 383.0 | 271.0 | 11.0 | 768.0 | |
| Not confirmed | 286.0 | 860.0 | 573.0 | 44.0 | 1,763.0 | |
| % Confirmed | 26.5 | 30.8 | 32.1 | 20.0 | 30.3 | |
| Death | 15.0 | 114.0 | 95.0 | 2.0 | 226.0 | |
| Alive | 374.0 | 1,129.0 | 1,126.0 | 69.0 | 2,698.0 | |
| % Dead | 3.9 | 9.2 | 7.8 | 2.8 | 7.7 | |
| Females | 87.0 | 387.0 | 386.0 | 28.0 | 888.0 | |
| Males | 302.0 | 856.0 | 835.0 | 43.0 | 2,036.0 | |
| % Female | 22.4 | 31.1 | 31.6 | 39.4 | 30.4 | |
Source: Afghanistan CDC. |
||||||
Overview of Crimean Congo Hemorrhagic Fever in 🇦🇫 Afghanistan
2022-2025
Disclaimer
Data based on the sitreps that are available WHO EMRO | Infectious disease outbreak situation reports | Information resources | Afghanistan .
WCO Afghanistan also maintains a dashboard.
CCHF in Afghanistan – Key Metrics
Overall burden of CCHF in Afghanistan 2022-2025, as of 2025, Epi-week 14
Since 2022, a total of 2924 suspected cases suspected CCHF cases were reported in Afghanistan.
A total of 768 confirmed cases CCHF confirmed cases were reported among suspected cases, leading to a positivity rate of 26%.
Overall, 226 deaths deaths among suspected cases ( CFR 8% ). If we were to assume that these were among confirmed cases, this would be a 29% CFR .
CCHF Situation Summary in 2025: Most Recent
| 🇦🇫 Key Metrics by Week with Totals | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 16 | 17 | Overall | Trends |
| Suspected Cases | 7.0 | 3.0 | 8.0 | 3.0 | 2.0 | - | 5.0 | 6.0 | 5.0 | 10.0 | 2.0 | 12.0 | 5.0 | 3.0 | - | - | 71.0 | |
| Confirmed | - | - | - | - | - | - | - | 2.0 | - | 3.0 | - | 5.0 | 1.0 | - | - | - | 11.0 | |
| Not confirmed | 5.0 | 2.0 | 7.0 | 2.0 | 1.0 | - | 4.0 | 3.0 | 4.0 | 5.0 | 2.0 | 5.0 | 4.0 | - | - | - | 44.0 | |
| % Confirmed | - | - | - | - | - | - | - | 40.0 | - | 37.5 | - | 50.0 | 20.0 | - | - | - | 20.0 | |
| Death | 1.0 | - | - | - | - | - | 1.0 | - | - | - | - | - | - | - | - | - | 2.0 | |
| Alive | 6.0 | 3.0 | 8.0 | 3.0 | 2.0 | - | 4.0 | 6.0 | 5.0 | 10.0 | 2.0 | 12.0 | 5.0 | 3.0 | - | - | 69.0 | |
| % Dead | 14.3 | - | - | - | - | - | 20.0 | - | - | - | - | - | - | - | - | - | 2.8 | |
| Females | 6.0 | 2.0 | 3.0 | 1.0 | - | - | - | 2.0 | 2.0 | 7.0 | - | 4.0 | - | 1.0 | - | - | 28.0 | |
| Males | 1.0 | 1.0 | 5.0 | 2.0 | 2.0 | - | 5.0 | 4.0 | 3.0 | 3.0 | 2.0 | 8.0 | 5.0 | 2.0 | - | - | 43.0 | |
| % Female | 85.7 | 66.7 | 37.5 | 33.3 | - | - | - | 33.3 | 40.0 | 70.0 | - | 33.3 | - | 33.3 | - | - | 39.4 | |
Source: Afghanistan CDC. |
||||||||||||||||||
CCHF Situation Summary in 2022-2025: Monthly Summary
| 🇦🇫 Key Metrics by Month with Totals | ||||||
|---|---|---|---|---|---|---|
| Indicator | Jan | Feb | Mar | Apr | Overall | Trends |
| Suspected Cases | 16.0 | 16.0 | 32.0 | - | 64.0 | |
| Confirmed | - | 2.0 | 9.0 | - | 11.0 | |
| Not confirmed | 12.0 | 11.0 | 16.0 | - | 39.0 | |
| % Confirmed | - | 15.4 | 36.0 | - | 22.0 | |
| Death | - | 1.0 | - | - | 1.0 | |
| Alive | 16.0 | 15.0 | 32.0 | - | 63.0 | |
| % Dead | - | 6.2 | - | - | 1.6 | |
| Females | 6.0 | 4.0 | 12.0 | - | 22.0 | |
| Males | 10.0 | 12.0 | 20.0 | - | 42.0 | |
| % Female | 37.5 | 25.0 | 37.5 | - | 34.4 | |
Source: Afghanistan CDC. |
||||||
| 🇦🇫 Key Metrics by Month with Totals | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Overall | Trends |
| Suspected Cases | 26.0 | 21.0 | 17.0 | 44.0 | 80.0 | 282.0 | 301.0 | 170.0 | 160.0 | 59.0 | 31.0 | 18.5 | 1,209.5 | |
| Confirmed | - | 1.0 | 1.0 | 4.0 | 15.0 | 102.0 | 81.0 | 36.0 | 11.0 | 11.0 | 6.0 | 1.5 | 269.5 | |
| Not confirmed | 18.0 | 16.0 | 12.0 | 23.0 | 62.0 | 131.0 | 73.0 | 79.0 | 87.0 | 39.0 | 20.0 | 9.0 | 569.0 | |
| % Confirmed | - | 5.9 | 7.7 | 14.8 | 19.5 | 43.8 | 52.6 | 31.3 | 11.2 | 22.0 | 23.1 | 14.3 | 32.1 | |
| Death | - | - | 1.0 | 1.0 | 4.0 | 29.0 | 28.0 | 15.0 | 11.0 | 4.0 | 1.0 | 1.0 | 95.0 | |
| Alive | 26.0 | 21.0 | 16.0 | 43.0 | 76.0 | 253.0 | 273.0 | 155.0 | 149.0 | 55.0 | 30.0 | 17.5 | 1,114.5 | |
| % Dead | - | - | 5.9 | 2.3 | 5.0 | 10.3 | 9.3 | 8.8 | 6.9 | 6.8 | 3.2 | 5.4 | 7.9 | |
| Females | 6.0 | 7.0 | 9.0 | 19.0 | 22.0 | 62.0 | 105.0 | 45.0 | 71.0 | 16.0 | 8.0 | 11.0 | 381.0 | |
| Males | 20.0 | 14.0 | 8.0 | 25.0 | 58.0 | 220.0 | 196.0 | 125.0 | 89.0 | 43.0 | 23.0 | 7.5 | 828.5 | |
| % Female | 23.1 | 33.3 | 52.9 | 43.2 | 27.5 | 22.0 | 34.9 | 26.5 | 44.4 | 27.1 | 25.8 | 59.5 | 31.5 | |
Source: Afghanistan CDC. |
||||||||||||||
| 🇦🇫 Key Metrics by Month with Totals | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Overall | Trends |
| Suspected Cases | 2.0 | 4.0 | 2.0 | 52.0 | 194.0 | 296.0 | 295.0 | 147.0 | 123.0 | 86.0 | 30.0 | 12.0 | 1,243.0 | |
| Confirmed | - | - | - | 12.0 | 81.0 | 130.0 | 81.0 | 48.0 | 6.0 | 24.0 | 1.0 | - | 383.0 | |
| Not confirmed | 2.0 | 4.0 | 2.0 | 40.0 | 113.0 | 166.0 | 214.0 | 99.0 | 117.0 | 62.0 | 29.0 | 12.0 | 860.0 | |
| % Confirmed | - | - | - | 23.1 | 41.8 | 43.9 | 27.5 | 32.7 | 4.9 | 27.9 | 3.3 | - | 30.8 | |
| Death | - | - | - | - | 4.0 | 19.0 | 55.0 | 18.0 | 9.0 | 5.0 | 4.0 | - | 114.0 | |
| Alive | 2.0 | 4.0 | 2.0 | 52.0 | 190.0 | 277.0 | 240.0 | 129.0 | 114.0 | 81.0 | 26.0 | 12.0 | 1,129.0 | |
| % Dead | - | - | - | - | 2.1 | 6.4 | 18.6 | 12.2 | 7.3 | 5.8 | 13.3 | - | 9.2 | |
| Females | - | 4.0 | 2.0 | 36.0 | 25.0 | 61.0 | 117.0 | 66.0 | 44.0 | 16.0 | 13.0 | 3.0 | 387.0 | |
| Males | 2.0 | - | - | 16.0 | 169.0 | 235.0 | 178.0 | 81.0 | 79.0 | 70.0 | 17.0 | 9.0 | 856.0 | |
| % Female | - | 100.0 | 100.0 | 69.2 | 12.9 | 20.6 | 39.7 | 44.9 | 35.8 | 18.6 | 43.3 | 25.0 | 31.1 | |
Source: Afghanistan CDC. |
||||||||||||||
| 🇦🇫 Key Metrics by Month with Totals | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Overall | Trends |
| Suspected Cases | - | - | - | 12.0 | 51.0 | 52.0 | 114.0 | 86.0 | 30.0 | 27.0 | 12.0 | 5.0 | 389.0 | |
| Confirmed | - | - | - | 4.0 | 5.0 | 25.0 | 18.0 | 34.0 | 10.0 | 7.0 | - | - | 103.0 | |
| Not confirmed | - | - | - | 8.0 | 46.0 | 27.0 | 96.0 | 52.0 | 20.0 | 20.0 | 12.0 | 5.0 | 286.0 | |
| % Confirmed | - | - | - | 33.3 | 9.8 | 48.1 | 15.8 | 39.5 | 33.3 | 25.9 | - | - | 26.5 | |
| Death | - | - | - | 1.0 | 1.0 | 6.0 | 6.0 | 1.0 | - | - | - | - | 15.0 | |
| Alive | - | - | - | 11.0 | 50.0 | 46.0 | 108.0 | 85.0 | 30.0 | 27.0 | 12.0 | 5.0 | 374.0 | |
| % Dead | - | - | - | 8.3 | 2.0 | 11.5 | 5.3 | 1.2 | - | - | - | - | 3.9 | |
| Females | - | - | - | 2.0 | 15.0 | 13.0 | 23.0 | 18.0 | 3.0 | 3.0 | 7.0 | 3.0 | 87.0 | |
| Males | - | - | - | 10.0 | 36.0 | 39.0 | 91.0 | 68.0 | 27.0 | 24.0 | 5.0 | 2.0 | 302.0 | |
| % Female | - | - | - | 16.7 | 29.4 | 25.0 | 20.2 | 20.9 | 10.0 | 11.1 | 58.3 | 60.0 | 22.4 | |
Source: Afghanistan CDC. |
||||||||||||||
CCHF seasonal incidence 2022-2025, as of 2025, Epi-week 14
- Higher incidence of both suspected and confirmed cases reported from mid-May to end of September.
- 81% of all suspected cases have been reported between epi-weeks 20 and 40.
- 88% of all confirmed cases have been reported between epi-weeks 20 and 40.
- In 2025, as of epi-week 14, 11 confirmed cases have been reported, a 450% increase compared to same period 2024.
- Higher incidence of both suspected and confirmed cases reported from mid-May to end of September.
- 81% of all suspected cases have been reported between epi-weeks 20 and 40.
- 88% of all confirmed cases have been reported between epi-weeks 20 and 40.
- In 2025, as of epi-week 14, 11 confirmed cases have been reported, a 450% increase compared to same period 2024.
Cases by Confirmation Status
Since 2022, a total of 2924 suspected cases suspected CCHF cases were reported in Afghanistan.
A total of 768 confirmed cases CCHF confirmed cases were reported among suspected cases, leading to a positivity rate of 26%.
Overall, 226 deaths deaths among suspected cases ( CFR 8% ). If we were to assume that these were among confirmed cases, this would be a 29% CFR .
CCHF in Afghanistan – Weekly Figures
Suspected Cases by Outcome and Epi-week
From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.
Among suspected cases, CFR is 8% .
If calculated only among confirmed cases, CFR would be 29%.
From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.
Among suspected cases, CFR is 8% .
If calculated only among confirmed cases, CFR would be 29%.
From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.
Among suspected cases, CFR is 8% .
If calculated only among confirmed cases, CFR would be 29%.
From sitrep information, it is not clear if death are reported among suspected cases or only among confirmed cases.
Among suspected cases, CFR is 8% .
If calculated only among confirmed cases, CFR would be 29%.
Suspected Cases by Sex and Epi-week
- Overall, 70% of suspected CCHF cases are males.
- As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
- Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
- Overall, 70% of suspected CCHF cases are males.
- As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
- Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
- Overall, 70% of suspected CCHF cases are males.
- As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
- Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
- Overall, 70% of suspected CCHF cases are males.
- As comparison, in 🇮🇶 Iraq approx. 59% of CCHF cases are males.
- Higher rate in Afghanistan may be explained by socio-economic roles of males, gender-bias in access to care and services and other factors.
Suspected CCHF Cases with Samples Tested in Laboratory
- Overall, 68% of suspected cases were tested.
- The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
- From informal reports, limited testing can be explained by lack of kit availability.
- Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
- Number of samples tested in 2022 is not reported in sitrep.
- Overall, 68% of suspected cases were tested.
- The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
- From informal reports, limited testing can be explained by lack of kit availability.
- Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
- Number of samples tested in 2022 is not reported in sitrep.
- Overall, 68% of suspected cases were tested.
- The proportion of cases tested ranges from 88% in 2023 to 69% in 2024.
- From informal reports, limited testing can be explained by lack of kit availability.
- Methods for testing (PCR and/or IgM and/or IgG) is not indicated in a systematic matter. Both would be needed, especially if patients present late to health facilities.
- Number of samples tested in 2022 is not reported in sitrep.
Suspected Cases by Laboratory Confirmation and Epi-week
| Indicator | 2024 | 2025 | Change (%) |
|---|---|---|---|
| Suspected Cases | 94 | 71 | ️↘️ -24.5% |
| Death | 2 | 2 | ️↔︎️ 0% |
| Suspected tested | 63 | 55 | ️↘️ -12.7% |
| Confirmed | 5 | 11 | ↗️ 120% |
| % Suspected tested | 67 | 77 | ↗️ 15.6% |
| % Confirmed among tested | 8 | 20 | ↗️ 152% |
| Indicator | 2023 | 2024 | Change (%) |
|---|---|---|---|
| Suspected Cases | 1,243 | 1,221 | ️↘️ -1.8% |
| Death | 114 | 95 | ️↘️ -16.7% |
| Suspected tested | 1,098 | 844 | ️↘️ -23.1% |
| Confirmed | 383 | 271 | ️↘️ -29.2% |
| % Suspected tested | 88 | 69 | ️↘️ -21.7% |
| % Confirmed among tested | 35 | 32 | ️↘️ -7.9% |
| Indicator | 2022 | 2023 | Change (%) |
|---|---|---|---|
| Suspected Cases | 389 | 1,243 | ↗️ 219.5% |
| Death | 15 | 114 | ↗️ 660% |
| Confirmed | 103 | 383 | ↗️ 271.8% |
| Suspected tested | – | 1,098 | – |
| % Suspected tested | – | 88 | – |
| % Confirmed among tested | – | 35 | – |
CCHF in Afghanistan – Yearly report
Suspected cases by Sex
Suspected cases by Outcome
Suspected cases by confirmation status
Suspected Cases by Testing Status and Epi-week
Thank you
Any questions or suggestions? Contact us: Anaïs Legand and Antoine Chaillon
As of 2025, Epi-week 14